COMPLEMENT SPLIT PRODUCTS INCREASED

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting COMPLEMENT SPLIT PRODUCTS INCREASED:

# Drug Count
0 PEGCETACOPLAN 2
1 AMLODIPINE 1
2 ECULIZUMAB 1
See all common drugs associated with COMPLEMENT SPLIT PRODUCTS INCREASED

COMPLEMENT SPLIT PRODUCTS INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGCETACOPLAN 2 0.0011
1 ECULIZUMAB 1 0.0000
2 AMLODIPINE 1 0.0000
See all drugs enriched for association with COMPLEMENT SPLIT PRODUCTS INCREASED

These drug classes are most commonly taken by patients reporting COMPLEMENT SPLIT PRODUCTS INCREASED:

# Drug class Count
0 Complement Inhibitor [EPC] 3
1 Calcium Channel Blocker [EPC] 1
2 Dihydropyridine Calcium Channel Blocker [EPC] 1
See all common drug classes associated with COMPLEMENT SPLIT PRODUCTS INCREASED

COMPLEMENT SPLIT PRODUCTS INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Complement Inhibitor [EPC] 3 0.0001
1 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
See all drug classes enriched for association with COMPLEMENT SPLIT PRODUCTS INCREASED